Fenlean (FLZ) is a tyrosine kinase Src inhibitor, a synthetic cyclic derivative of squamous amide from Annona glabra, with cytoprotective activity, which protects tyrosine hydroxylase function in a chronic MPTP/prostaglandin-type mouse model of Parkinsons disease.Fenlean inhibits the production of Abeta in the mitochondria, which may be useful in the study of age-related macular degeneration and Parkinsons disease. and Parkinsons.
Molecular Weight:
449.5
Purity:
98.99%
CAS Number:
[863193-70-8]
Formula:
C26H27NO6
Target:
Beta Amyloid|||Src
T31773
* VAT and and shipping costs not included. Errors and price changes excepted